GAMMA Investing »

Enanta Pharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $750 43 17.47
2023-12-31 $521 43 12.14

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Enanta Pharmaceuticals

Vanguard Group
Millennium Management
Krensavage Asset Management
D. E. Shaw & Co
Assenagon Asset Management
Jacobs Levy Equity Management
Two Sigma Investments
Tang Capital Management
Two Sigma Advisers
Ubs Global Asset Management Americas
AQR Capital Management
Goldman Sachs Group
Dimensional Fund Advisors
Jpmorgan Chase & Co
Charles Schwab Investment Management

View all funds holding Enanta Pharmaceuticals